Skip to content

BSX

Boston Scientific Corporation

Cash flow statement

Cash flow statement
Line, in USDLast 12 months2025202420232022202120202019201820172016201520142013201220112010200920082007
Operating cash flow4.23B4.53B3.44B2.50B1.53B1.87B1.51B1.84B0.31B1.43B1.18B0.69B1.27B1.11B1.28B1.01B0.33B0.84B1.22B0.93B
903M876M790M711M588M554M376M461M316M319M376M247M259M245M226M304M272M312M362M363M
Free cash flow3.33B3.66B2.65B1.79B0.94B1.32B1.13B1.38B−6.0M1.11B0.81B0.44B1.01B0.87B1.05B0.70B53M0.52B0.85B0.57B
Depreciation and amortization1.43B1.37B1.27B1.20B1.14B1.09B1.12B1.01B0.90B0.84B0.82B0.77B0.73B0.69B0.68B0.72B0.82B0.83B0.86B0.92B
Stock-based compensation313M299M266M233M220M194M170M157M140M127M116M107M103M105M108M128M150M144M138M122M
Buybacks————00535M00—00125M500M600M492M————
Dividends paid——028M55M55M28M00———————————
Free cash flow margin15.8%18.2%15.8%12.6%7.4%11.1%11.4%12.8%−0.1%12.2%8.9%5.5%13.5%12.2%14.5%9.2%0.7%6.4%10.6%6.8%